Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

«We are confident about the second half of the year»

Investors seem to have little interest in biotech stocks at the moment. Is the skepticism investors are showing justified and how does this compare with the fundamental development of the sector or the individual companies? These and other questions are explored in the video update with Dr. Daniel Koller, Head of the Investment Management Team.
21.07.2023 - Daniel Koller
Video update with Dr. Daniel Koller Q2 2023